Respiratory viruses and severe lower respiratory tract complications in hospitalized patients

Chest

Volumn 125, Issue 3, 2004, Pages 1033-1039

  Garbino, Jorge ^a   Gerbase, Margaret W ^a   Wunderli, Werner ^a   Kolarova, Lenka ^a   Nicod, Laurent P ^a   Rochat, Thierry ^a   Kaiser, Laurent ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Adenovirus; BAL; Immunocompromised host; Influenza; Parainfluenza virus; Respiratory syncytial virus; Rhinovirus; Viral infection

Indexed keywords

ANTIBIOTIC AGENT;

ADENOVIRUS; ADOLESCENT; ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBEROPTIC BRONCHOSCOPY; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTENSIVE CARE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MORTALITY; PARAINFLUENZA VIRUS; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; SPIROMETRY; TREATMENT OUTCOME; VIRUS IDENTIFICATION; VIRUS INFECTION;

EID: 1642338000     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.3.1033     Document Type: Article

References (39)

1. Simonsen L, Fukuda K, Schonberger LB, et al. The impact of influenza epidemics on hospitalisations. J Infect Dis 2000; 181:831-837
2. Evans ME, Hall KL, Berry SE. Influenza control in acute care hospitals. Am J Infect Control 1997; 25:357-362
3. Whimbey E, Englund JA, Couch RB. Community respiratory virus infection in immunocompromised patients with cancer. Am J Med 1997; 102:10-18
4. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102:44-47
5. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchison Cancer Research Center experience. Am J Med 1997; 102:27-30
6. Ghosh S, Champlin R, Couch R, et al. Rhinovirus infections in myelosuppressed adult bone marrow transplant recipients. Clin Infect Dis 1999; 29:528-532
7. Apalsch AM, Green M, Ledesma-Medina J, et al. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20:394-399
8. Munoz FM, Piedra PA, Demmler GJ. Disseminated adenovirus disease in immunocompromised and immunocompetent children. Clin Infect Dis 1998; 27:1194-1200
9. Weber J, Yang JC, Topalian SL, et al. Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 1993; 11:499-506
10. Connolly MG Jr, Baugham RP, Dohn MN, et al. Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. Chest 1994; 105:1775-1781
11. Rabella N, Rodriguez P, Labeaga R, et al. Conventional respiratory viruses recovered from immunocompromised patients: clinical considerations. Clin Infect Dis 1999; 28:1043-1048
12. Malcolm E, Arruda E, Hayden FG, et al. Clinical features of patients with acute respiratory illness and rhinovirus in their bronchoalveolar lavages. J Clin Virol 2001; 21:9-16
13. Palmer SM, Henshaw NG, Howell DN, et al. Community respiratory viral infection in adult lung transplant recipients. Chest 1998; 113:944-950
14. Arola M, Ruuskanen O, Ziegler T, et al. Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J 1995; 14:690-694
15. Dusheiko G. Side effects of α interferon in chronic hepatitis C. Hepatology 1997; 26 (suppl 1):112S-121S
16. Yousuf HM, Englund J, Couch R, et al. Influenza among hospitalized adults with leukemia. Clin Infect Dis 1997; 24:1095-1099
17. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995; 21:376-379
18. Okamoto Y, Kudo K, Shirotori K, et al. Detection of genomic sequences of respiratory syncytial virus in otitis media with effusion in children. Ann Otol Rhinol Laryngol 1992; 157(Suppl):7-10
19. Heagy W, Crumpacker C, Lopez PA, et al. Inhibition of immune functions by antiviral drugs. J Clin Invest 1991; 87:1916-1924
20. Whimbey E, Champlin RE, Couch RB, et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22:778-782
21. Reuman PD, Bernstein DI, Keefer MC, et al. Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A. Antiviral Res 1989; 11:27-40
22. Baron S, Coppenhaver DH, Doanzani F. Introduction to the interferon system. In: Baron S, ed. Interferon: principles and medical applications. Galveston, TX: UTMN, 1992; 1-15
23. Pohl C, Green M, Wald ER, et al. Respiratory syncytial virus infections in pediatric liver transplant recipients. J Infect Dis 1992; 165:166-169
24. Wendt CH, Fox JM, Hertz MI. Paramyxovirus infection in lung transplant recipients. J Heart Lung Transplant 1995; 14:479-485
25. Smith GB, Purcell RH, Chanock RM. Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. Am Rev Respir Dis 1967; 95:689-690
26. Englund JA, Piedra PA, Whimbey E. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med 1997; 102:61-70
27. Dominguez KD, Mercier RC. Treatment of RSV pneumonia in adults: evidence of ribavirin effectiveness? Ann Pharmacother 1999; 33:739-741
28. Asian T, Fassas AB, Desikan R, et al. Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy. Bone Marrow Transplant 1999; 24:505-509
29. Harrington RD, Hooton TM, Hackman RC, et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165:987-993
30. Whimbey E, Champlin RE, Englund JA, et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 16:393-399
31. Gubareva LV, Hayden FG, Kaiser L. Influenza virus neuraminidase inhibitors. Lancet 2000; 355:827-835
32. Kaiser L, Crump CE, Hayden FG. In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. Antiviral Res 2000; 47:215-220
33. Rotbart HA, Webster AD. Treatment of potentially life-threatening enterovirus infections with pleconaril: Pleconaril Treatment Registry Group. Clin Infect Dis 2001; 32:228-235
34. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997; 102:2-9
35. Garcia R, Raad I, Abi-Said D, et al. Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients. Infect Control Hosp Epidemiol 1997; 18:412-416
36. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997; 47(RR-6):1-26
37. Guidelines for prevention of nosocomial pneumonia. MMWR Morb Mortal Wkly Rep 2000; 46 (RR-1):1-79
38. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: randomised controlled trial. Lancet 2000; 355:93-97
39. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 1997; 175:1-6